Primary practice
Peter Morton UCLA Medical Building
Los Angeles, California
Find Dr. Pantuck's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Pantuck practices at Peter Morton UCLA Medical Building in Los Angeles, California.
Dr. Pantuck's NPI, 1386663227, was assigned on July 19, 2006. Dr. Pantuck graduated from Rutgers Robert Wood Johnson Medical School in 1993. Dr. Pantuck holds California license G85029.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Pantuck's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Pantuck's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Pantuck is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Urology. Dmand AI also links Dr. Pantuck to 1 more hospital and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pantuck practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Peter Morton UCLA Medical Building | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Urology is Dr. Pantuck's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Pantuck is board certified in urology by the American Board of Urology. Dmand AI has Dr. Pantuck's licenses on file in 3 states: California, Florida and New Jersey.
Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, prostate cancer, urinary endoscopy and urine flow blockage among the conditions Dr. Pantuck treats.
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 574 Medicare services from Dr. Pantuck across 10 procedure codes in 2024, for 245 Medicare patients. Medicare paid $57,240 for them.
Medians across 1,310 urologists in California with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Pantuck?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pantuck and other urologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 245 Medicare patients who saw Dr. Pantuck in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Pantuck's median patient age at 70, with 9% women.
CMS leaves out age groups with fewer than 11 patients.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 70
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Pantuck wrote 726 Medicare Part D claims for 187 patients. 85% of them were for generic drugs. CMS names the drug for 645 of them, across 11 drugs with 11 or more claims each, at $68,258 in total drug cost. In 2023, CMS named 545 claims across 10 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 11 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Pantuck for performance year 2024, reported as part of a group. Dr. Pantuck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pantuck as offering telehealth.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links 57 papers to Dr. Pantuck, published from 2010 to 2024. 2017 was the busiest year, with 11. Dr. Pantuck has published most often in Eur Urol. Dr. Pantuck's most frequent co-authors are Arie Belldegrun, MD, Karim Chamie, MD and Alexandra Drakaki, MD.
See who Dr. Pantuck researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pantuck works with, so you can find a warm path to the right urologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dmand AI links Dr. Pantuck to 12 clinical trials, 3 of them phase 2 studies. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Prostatic Hyperplasia. Jonsson Comprehensive Cancer Center sponsors the most, 5.
Conditions in Dr. Pantuck's trials
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
CMS Open Payments shows 114 general payments to Dr. Pantuck from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Pfizer Inc. paid the most, $98,486. It also lists 4 research payments totaling $4,878 in 2020.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dmand AI lists 1 award for Dr. Pantuck.
Source: Dmand AI Professional Profile Data
Dr. Pantuck graduated from Rutgers Robert Wood Johnson Medical School in 1993. Dr. Pantuck is a member of ACS.
Source: Dmand AI Professional Profile Data
Dr. Pantuck is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Source: Dmand AI Insurance Network Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Allan Pantuck's NPI number is 1386663227. It was assigned on July 19, 2006, and it is active in the NPI Registry.
Dr. Allan Pantuck is a urologist in Los Angeles, California. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Dr. Pantuck practices at 200 Medical Plz, Los Angeles, CA 90024. Dr. Pantuck's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dmand AI also links Dr. Pantuck to 1 hospital and 1 group practice or clinic.
The practice phone on file for Dr. Pantuck is (310) 794-9206.
Dr. Pantuck holds California license G85029, one of the licenses on file in 3 states.
Dmand AI has state licenses on file for Dr. Pantuck in California (1999 to 2027), Florida (2017 to 2019) and New Jersey (1995 to 1999).
Dr. Pantuck is affiliated with Ronald Reagan UCLA Medical Center. Dmand AI links Dr. Pantuck to 1 more hospital.
Dr. Pantuck is linked to UCLA Urology.
Yes. CMS data shows Dr. Pantuck billed Medicare for 574 services in 2024, and Dr. Pantuck accepts Medicare assignment.
Yes. The CMS Doctors and Clinicians file lists Dr. Pantuck as offering telehealth services.
Dr. Pantuck's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.
CMS counts 245 Medicare patients who saw Dr. Pantuck in 2024, with an average age of 74.
Yes. Dr. Pantuck is board certified in urology by the American Board of Urology.
In 2024, Dr. Pantuck's most billed Medicare services were office visit, established patient (99213), injected or infused drug (J0696) and surgery: male reproductive system (55700).
Dr. Pantuck graduated from Rutgers Robert Wood Johnson Medical School in 1993.
In 2024 Medicare Part D data, Dr. Pantuck's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Myrbetriq.
CMS Open Payments shows $102,879 in general payments to Dr. Pantuck from 15 companies from 2016 to 2025. The largest total came from Pfizer Inc.
Dr. Pantuck graduated from medical school in 1993, 33 years ago.
Dmand AI links 57 publications to Dr. Pantuck, published from 2010 to 2024. Dr. Pantuck has worked on 12 clinical trials.
Dr. Pantuck's most frequent co-authors are Arie Belldegrun, MD (22 shared papers), Karim Chamie, MD (9 shared papers) and Alexandra Drakaki, MD (9 shared papers).
Dr. Pantuck is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to urology practices?
See urologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.